Tattersall M H, Ganeshaguru K, Hoffbrand A V
Antibiot Chemother (1971). 1980;28:94-101. doi: 10.1159/000386065.
Deoxyribonucleoside triphosphate pools have been measured in nucleated bone marrow cells from normal subjects and from patients with leukaemia. The deoxyribonucleoside triphosphate (dNTP) concentrations were increased approximately 3-fold in patients with leukaemia and other myeloproliferative diseases. The dNTP concentrations in bone marrow from patients with drug-resistant acute leukaemia were also measured, and in general they were lower in resistant than sensitive marrow cells, although the deoxycytidine triphosphate level was relatively increased in the resistant cells. dNTP concentrations have also been measured in cultured human leukaemic cells and phytohaemagglutinin-stimulated normal lymphocytes. As in other cells, the dNTP concentrations have been noted to fluctuate during the cell cycle and in relationship to the cellular proliferative rate. Measurement of dNTP concentrations in human bone marrow and leukaemic cells is practical but there are major problems relating to the preparation of bone marrow for dNTP measurement. Further studies of dNTP pool changes in animals following drug treatment in vivo are necessary in order to improve methods of preparing cell populations for these biochemical measurements.
已对正常受试者和白血病患者有核骨髓细胞中的脱氧核糖核苷三磷酸池进行了测定。白血病患者和其他骨髓增殖性疾病患者的脱氧核糖核苷三磷酸(dNTP)浓度增加了约3倍。还测定了耐药性急性白血病患者骨髓中的dNTP浓度,总体而言,耐药骨髓细胞中的dNTP浓度低于敏感骨髓细胞,尽管耐药细胞中的三磷酸脱氧胞苷水平相对增加。也已在培养的人白血病细胞和植物血凝素刺激的正常淋巴细胞中测定了dNTP浓度。与其他细胞一样,已注意到dNTP浓度在细胞周期中以及与细胞增殖速率相关的情况下会发生波动。测量人骨髓和白血病细胞中的dNTP浓度是可行的,但在为dNTP测量制备骨髓方面存在重大问题。为了改进用于这些生化测量的细胞群体制备方法,有必要进一步研究动物在体内药物治疗后dNTP池的变化。